Trial close-out documentation
Complete final documentation requirements including close-out visit reports, final IP accountability, IRB notifications, and regulatory authority notifications.
The email that signals the end
It is 2:17 PM on a Friday in early March when Dr. Rebecca Hwang receives an email she has been anticipating for eighteen months. The subject line reads: "ELEVATE-HF Trial - Last Subject Last Visit Notification."
The Phase 2 heart failure trial at Lakewood Regional Medical Center in Minneapolis, Minnesota, has enrolled 47 participants, administered over 500 doses of investigational product, documented three serious adverse events (all resolved without sequelae), and generated reams of source documentation. Now, with the final participant's Week 52 visit complete, the clinical phase of the trial is officially over.